Aurisco Pharmaceutical Co Ltd Capital Reinvestment Ratio
Aurisco Pharmaceutical Co Ltd capital reinvestment ratio. Aurisco Pharmaceutical Co Ltd (605116) has a Capital Reinvestment Ratio of 1.63x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥332.41 Million) in capital expenditures (CN¥540.28 Million). Check Aurisco Pharmaceutical Co Ltd (605116) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aurisco Pharmaceutical Co Ltd (2017–2024)
Capital reinvestment ratio of Aurisco Pharmaceutical Co Ltd from 2017 to 2024. This chart tracks Aurisco Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore 605116 net asset momentum to track the company's year-over-year net asset growth rate.
Aurisco Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2017–2024)
Aurisco Pharmaceutical Co Ltd capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see Aurisco Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.63x | CN¥332.41 Million | CN¥540.28 Million | ▲ +105.2% |
| 2023 | 0.79x | CN¥385.61 Million | CN¥305.48 Million | ▼ -39.0% |
| 2022 | 1.30x | CN¥166.41 Million | CN¥216.23 Million | ▲ +4.5% |
| 2021 | 1.24x | CN¥201.57 Million | CN¥250.61 Million | ▲ +67.9% |
| 2020 | 0.74x | CN¥214.48 Million | CN¥158.80 Million | ▲ +83.8% |
| 2019 | 0.40x | CN¥179.90 Million | CN¥72.47 Million | ▼ -53.0% |
| 2018 | 0.86x | CN¥109.77 Million | CN¥94.14 Million | ▼ -5.1% |
| 2017 | 0.90x | CN¥117.91 Million | CN¥106.60 Million | — |